Vegan diet reduces insulin use by 28% in type 1 diabetes

A low-fat vegan diet has shown promise in helping people with type 1 diabetes cut their daily insulin needs by nearly 30%, according to new research. The study, published in BMC Nutrition, found that participants on this plant-based plan also saved on insulin costs without restricting calories or carbohydrates. In contrast, those following a portion-controlled diet saw no significant changes.

The research, a secondary analysis of a 2024 clinical trial conducted by the Physicians Committee for Responsible Medicine, involved comparing a low-fat vegan diet to a portion-controlled approach in individuals with type 1 diabetes. Over 12 weeks, participants on the vegan diet reduced their total daily insulin dose by 28%, equivalent to 12.1 units per day. This group also experienced a 27% drop in daily insulin expenses, amounting to $1.08 less per day, while the comparison group showed no notable reductions.

Type 1 diabetes requires insulin because the body does not produce enough of the hormone, which helps move glucose into cells for energy. Some patients develop insulin resistance, where cells do not respond well to insulin, often exacerbated by dietary fat. The study suggests the vegan diet improved insulin sensitivity, allowing better glucose management.

Beyond insulin use, the original 2024 trial reported further benefits for the vegan group, including an average weight loss of 11 pounds, better glycemic control, lower cholesterol levels, and improved kidney function. These outcomes occurred without calorie or carbohydrate restrictions.

The findings are particularly relevant amid rising insulin costs in the United States. National spending on insulin tripled over the past decade to $22.3 billion in 2022, with prices increasing 24% from 2017 to 2022 after inflation adjustments.

"As insulin prices continue to rise, people with type 1 diabetes should consider a low-fat vegan diet, which can help improve their insulin sensitivity and reduce the amount of insulin they need, potentially saving them hundreds of dollars a year," said Hana Kahleova, MD, PhD, lead author and director of clinical research at the Physicians Committee for Responsible Medicine.

The study was published in BMC Nutrition in 2025, with full details available via DOI: 10.1186/s40795-025-01175-2.

Mga Kaugnay na Artikulo

Split-image illustration of Mediterranean vs low-fat vegan meals with scale showing greater vegan weight loss from trial study.
Larawang ginawa ng AI

Low-Fat Vegan Diet Linked to Greater Weight Loss Than Mediterranean Pattern in Trial Analysis

Iniulat ng AI Larawang ginawa ng AI Fact checked

A secondary analysis of a randomized clinical trial reports that a low-fat vegan diet was associated with greater weight loss than a Mediterranean diet, even when the vegan menu included plant foods such as refined grains and potatoes that are labeled “unhealthful” in a common plant-based diet scoring system. The benefits were linked to replacing animal products with plant foods and limiting added oils and nuts, according to researchers from the Physicians Committee for Responsible Medicine in a study published in Frontiers in Nutrition.

A team led by Leonardo Ferreira at the Medical University of South Carolina is developing a novel therapy combining lab-made insulin-producing cells with engineered immune cells to protect them. Funded by $1 million from Breakthrough T1D, the approach aims to restore beta cell function without immunosuppressive drugs. This strategy builds on prior research and targets all stages of the disease.

Iniulat ng AI

A large UK study indicates that statins lower death and heart event risks for adults with type 2 diabetes, regardless of their predicted cardiovascular risk. Benefits appeared even among low-risk individuals, questioning current prescribing guidelines. Side effects remained minimal.

A small study suggests that sitting by a window to receive natural daylight can help manage blood sugar levels in people with type 2 diabetes. Researchers found that participants exposed to natural light spent more time within healthy glucose ranges compared to those under artificial lighting. The findings highlight the role of circadian rhythms in metabolic health.

Iniulat ng AI Fact checked

Preliminary research published in Neurology suggests that GLP-1 medications, including drugs such as Ozempic, may be associated with a modestly lower risk of developing epilepsy in people with type 2 diabetes compared with DPP-4 inhibitors. In the analysis, GLP-1 users were 16 percent less likely to develop epilepsy after statistical adjustment, but researchers stress that the findings show an association, not proof of cause and effect.

A new study challenges the hype around intermittent fasting, finding that limiting eating to an eight-hour window does not improve metabolic health if calorie intake remains the same. Researchers from German institutions observed shifts in the body's internal clocks but no changes in insulin sensitivity or cardiovascular markers. The results suggest that calorie control, rather than meal timing alone, drives potential health gains.

Iniulat ng AI

A clinical trial from the University of Bonn shows that consuming mostly oatmeal for two days can reduce harmful LDL cholesterol by 10 percent in people with metabolic syndrome. The benefits, including changes in gut bacteria, persisted for six weeks. Participants also experienced modest weight loss and lower blood pressure.

 

 

 

Gumagamit ng cookies ang website na ito

Gumagamit kami ng cookies para sa analytics upang mapabuti ang aming site. Basahin ang aming patakaran sa privacy para sa higit pang impormasyon.
Tanggihan